Xiaolan Qian

4.0k total citations
70 papers, 3.1k citations indexed

About

Xiaolan Qian is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Xiaolan Qian has authored 70 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 26 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Xiaolan Qian's work include HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cell Adhesion Molecules Research (9 papers). Xiaolan Qian is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Cell Adhesion Molecules Research (9 papers). Xiaolan Qian collaborates with scholars based in United States, China and United Kingdom. Xiaolan Qian's co-authors include Douglas R. Lowy, William C. Dougall, Mark I. Greene, Takuro Wada, Alex G. Papageorge, Mark I. Greene, William C. Vass, Allan Sheppard, James G. McNally and Tatiana Karpova and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Xiaolan Qian

69 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Qian United States 31 2.0k 1.2k 565 540 374 70 3.1k
Iris Alroy Israel 19 2.2k 1.1× 1.7k 1.4× 833 1.5× 528 1.0× 237 0.6× 27 3.8k
Norbert Prenzel Germany 9 2.2k 1.1× 1.3k 1.0× 421 0.7× 325 0.6× 424 1.1× 9 3.6k
Christian Wallasch Germany 11 2.3k 1.1× 1.1k 0.9× 466 0.8× 340 0.6× 280 0.7× 14 3.5k
Joan Levy United States 28 2.6k 1.3× 955 0.8× 197 0.3× 545 1.0× 406 1.1× 58 3.6k
Elena Burova Russia 20 2.1k 1.0× 632 0.5× 436 0.8× 279 0.5× 500 1.3× 52 3.4k
Bela Anand‐Apte United States 35 2.8k 1.4× 673 0.5× 507 0.9× 832 1.5× 1.2k 3.2× 87 4.9k
Josep Baulida Spain 24 3.9k 1.9× 2.6k 2.1× 310 0.5× 732 1.4× 932 2.5× 33 5.6k
Laura Rosanò Italy 35 2.1k 1.0× 915 0.7× 140 0.2× 418 0.8× 671 1.8× 63 3.7k
Steven Swendeman United States 27 1.7k 0.8× 599 0.5× 197 0.3× 283 0.5× 267 0.7× 35 2.6k
W A Grasser United States 23 1.4k 0.7× 1.3k 1.0× 250 0.4× 328 0.6× 105 0.3× 33 3.0k

Countries citing papers authored by Xiaolan Qian

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Qian more than expected).

Fields of papers citing papers by Xiaolan Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Qian. The network helps show where Xiaolan Qian may publish in the future.

Co-authorship network of co-authors of Xiaolan Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Qian. A scholar is included among the top collaborators of Xiaolan Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Qian. Xiaolan Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Xiaolan, et al.. (2025). Barriers and facilitators to physical activity after transcatheter aortic valve replacement: A mixed-methods study. Journal of Rehabilitation Medicine. 57. jrm39974–jrm39974. 1 indexed citations
2.
Tripathi, Brajendra K., Xiaolan Qian, Marian E. Durkin, et al.. (2024). The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export. Nature Cancer. 5(12). 1902–1918. 1 indexed citations
3.
Hu, Bo, Xiaolan Qian, Ping Qian, et al.. (2022). Advances in the functions of CTRP6 in the development and progression of the malignancy. Frontiers in Genetics. 13. 985077–985077. 8 indexed citations
4.
Tripathi, Brajendra K., Xiaolan Qian, Dunrui Wang, et al.. (2021). Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein. Nature Communications. 12(1). 6941–6941. 12 indexed citations
5.
Tang, Jie, Bo Hu, Huaping Zheng, et al.. (2021). 2,2′,4,4′-Tetrabromodiphenyl ether (BDE-47) activates Aryl hydrocarbon receptor (AhR) mediated ROS and NLRP3 inflammasome/p38 MAPK pathway inducing necrosis in cochlear hair cells. Ecotoxicology and Environmental Safety. 221. 112423–112423. 27 indexed citations
6.
Wang, Dunrui, Xiaolan Qian, Beatriz Sánchez‐Solana, et al.. (2020). Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function. Cancer Research. 80(17). 3568–3579. 15 indexed citations
7.
Jiang, Jian, et al.. (2020). Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel. Medicine. 99(28). e21203–e21203. 1 indexed citations
8.
Tripathi, Brajendra K., Xiaolan Qian, Ming Zhou, et al.. (2019). SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions. The Journal of Cell Biology. 218(9). 3060–3076. 11 indexed citations
9.
Tripathi, Brajendra K., Xiaolan Qian, Ming Zhou, et al.. (2017). Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1. The Journal of Cell Biology. 216(12). 4255–4270. 30 indexed citations
10.
Qian, Xiaolan, Wei Zhang, Yubing Zhou, et al.. (2014). Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. European Journal of Pharmacology. 746. 206–212. 77 indexed citations
11.
Du, Xiaoli, Xiaolan Qian, Alex G. Papageorge, et al.. (2012). Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells. Cancer Research. 72(17). 4405–4416. 42 indexed citations
12.
Qian, Xiaolan, Marian E. Durkin, Dunrui Wang, et al.. (2012). Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15INK4b and p16Ink4a , Leading to Neoplastic Transformation and Poor Prognosis in Human Cancer. Cancer Research. 72(22). 5900–5911. 25 indexed citations
13.
Asnaghi, Laura, William C. Vass, Rafael Quadri, et al.. (2010). E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene. 29(19). 2760–2771. 61 indexed citations
14.
Wu, Chuan-Jin, Xiaolan Qian, & Donald M. O’Rourke. (1999). Sustained Mitogen-Activated Protein Kinase Activation Is Induced by Transforming erbB Receptor Complexes. DNA and Cell Biology. 18(10). 731–741. 30 indexed citations
15.
Park, Byeong‐Woo, Donald M. O’Rourke, Qiang Wang, et al.. (1999). Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases. Proceedings of the National Academy of Sciences. 96(11). 6434–6438. 16 indexed citations
16.
Qian, Xiaolan, et al.. (1999). Domain-specific Interactions between the p185 and Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes. Journal of Biological Chemistry. 274(2). 574–583. 30 indexed citations
17.
Qian, Xiaolan, Donald M. O’Rourke, Hongbo Zhao, & M I Greene. (1996). Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.. PubMed. 13(10). 2149–57. 18 indexed citations
18.
Qian, Xiaolan, et al.. (1995). Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.. PubMed. 10(1). 211–9. 31 indexed citations
19.
Dougall, William C., Xiaolan Qian, Norman Peterson, et al.. (1994). The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.. PubMed. 9(8). 2109–23. 158 indexed citations
20.
Brown, Valerie I., Neelima Shah, Robert C. Smith, et al.. (1994). Demonstration by Two-Color Flow Cytometry That Tyrosine Kinase Activity Is Required for Down-Modulation of the Oncogenic neu Receptor. DNA and Cell Biology. 13(2). 193–209. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris Alroy Breakdown of academic impact, for papers by Norbert Prenzel Breakdown of academic impact, for papers by Christian Wallasch Breakdown of academic impact, for papers by Joan Levy Breakdown of academic impact, for papers by Elena Burova Breakdown of academic impact, for papers by Bela Anand‐Apte Breakdown of academic impact, for papers by Josep Baulida Breakdown of academic impact, for papers by Laura Rosanò Breakdown of academic impact, for papers by Steven Swendeman Breakdown of academic impact, for papers by W A Grasser
Rankless by CCL
2026